- ASSISTANT PROFESSOR Medicine, Cardiology
- ASSISTANT PROFESSOR Pathology
Dr.K-Raman Purushothaman has obtained his M.D degree from Madras University and completed his post-doctoral training in pathology at Madras Medical College and Jawaharlal Nehru Institute of Post Graduate Medical Education & Research Center, in India. He joined with Dr.Pedro Moreno's Cardiovascular Research Laboratory as Director of Histology at the University of Kentucky and involved in the histopathological evaluation of human and experimental atherosclerosis.
His current research focuses on histopathologic quantification of atherosclerosis. He is involved in detailed advanced immunohistochemistry techniques using the double- labeling, bi-color chromogens for studying the neovascularization of the plaque. He is also involved in the study of intimal, medial and adventitial, plaque compositional changes in the plaque progression and regression and the risk factors (diabetes mellitus, cigarette smoking and hypercholesterolemia) involving the association in inflammation and plaque rupture.
His animal experimental studies involves pre-clinical evaluation of drug eluting stents by analyzing the effects of drug eluting stents in stabilizing the vulnerable rabbit aortic plaques and study the plaque composition. His efforts will be to study the neovascularization and the implications in plaque rupture in diabetics versus non-diabetics based on the preliminary analysis in human aortic atherosclerotic plaques and to develop an animal model to study the mechanism involved in neovascularization in atherosclerotic plaques.
Moreno PR, Lodder RA, Purushothaman KR, Charash WE, O'Connor WN, Muller JE. Detection of lipid pool, thin fibrous cap and inflammatory cell infiltration in human aortic atherosclerotic plaques by near infrared spectroscopy. Circulation 2002 February 26; 105(8): 923-927.
Moreno PR, Purushothaman KR, Fuster V, O'Connor WN. Intimomedial damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta. Implications for plaque vulnerability Circulation 2002; 105: 2502-2509.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Purushothaman did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Annenberg Building Floor 24th Floor Room 24-270
1468 Madison Avenue
New York, NY 10029